EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice

Zhenfei Wang, Weiyang Sun, Dongxu Li, Yue Sun, Menghan Zhu, Wenqi Wang, Yiming Zhang, Entao Li, Feihu Yan, Tiecheng Wang, Na Feng, Songtao Yang und 2 weitere

Virus Research · 2024

DOI: 10.1016/j.virusres.2024.199378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virus Research, 2024. Verfasst von Zhenfei Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China; College of Animal Science and Technology, Colleg…. Hauptthemen laut MEDLINE: Influenza B virus, Antibodies, Viral, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a significant threat to human health globally. It is crucial to develop a vaccine to reduce the effect of the virus on public health, economy, and society and regulate the transmission of SARS-CoV-2. Influenza B virus (IBV) can be used as a vector that does not rely on the current circulating influenza A strains. In this study, we constructed an IBV-based vector vaccine by inserting a receptor-binding domain (RBD) into a non-structural protein 1 (NS1)-truncated gene (rIBV-NS110-RBD). Subsequently, we assessed its safety, immunogenicity, and protective efficacy against SARS-CoV-2 in mice, and observed that it was safe in a mouse model. Intranasal administration of a recombinant rIBV-NS110-RBD vaccine induced high levels of SARS-CoV-2-specific IgA and IgG antibodies and T cell-mediated immunity in mice. Administering two doses of the intranasal rIBV-NS110-RBD vaccine significantly reduced the viral load and lung damage in mice. This novel IBV-based vaccine offers a novel approach for controlling the SARS-CoV-2 pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza B virusAntibodies, ViralSARS-CoV-2COVID-19Vaccines, AttenuatedCOVID-19 VaccinesMice, Inbred BALB CAnimalsMiceFemaleAdministration, IntranasalHumansSpike Glycoprotein, CoronavirusInfluenza VaccinesImmunoglobulin ADisease Models, AnimalImmunoglobulin GViral LoadAntibodies, Neutralizing

Stichwörter der Autor:innen

Influenza virus-vector vaccineIntranasal vaccinationMiceSARS-CoV-2Spike RBD

Substanzen

Antibodies, ViralVaccines, AttenuatedCOVID-19 VaccinesSpike Glycoprotein, CoronavirusInfluenza VaccinesImmunoglobulin AImmunoglobulin GAntibodies, Neutralizing

Autor:innen und Institutionen

  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China; College of Animal Science and Technology, College of Veterinary and Medicine, Jilin Agricultural University, Changchun…
  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China; College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.
  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China; Jilin Province Key Laboratory on Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, No…
  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China; Henan International Joint Laboratory for Nuclear Protein Regulation, Henan University, School of Basic Medical Science…
  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China; Key Laboratory of Animal Resistant Biology of Shandong, College of Life Sciences, Shandong Normal University, Jinan, C…

Zitieren

APA

Wang, Z., Sun, W., Li, D., Sun, Y., Zhu, M., Wang, W., Zhang, Y., Li, E., Yan, F., Wang, T., Feng, N., Yang, S., Xia, X., & Gao, Y. (2024). A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice. Virus Research. https://doi.org/10.1016/j.virusres.2024.199378

Vancouver

Wang Z, Sun W, Li D, Sun Y, Zhu M, Wang W, et al. A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice. Virus Research. 2024. doi:10.1016/j.virusres.2024.199378

BibTeX
@article{Wang2024,
  author = {Wang, Zhenfei and Sun, Weiyang and Li, Dongxu and Sun, Yue and Zhu, Menghan and Wang, Wenqi and Zhang, Yiming and Li, Entao and Yan, Feihu and Wang, Tiecheng and Feng, Na and Yang, Songtao and Xia, Xianzhu and Gao, Yuwei},
  title = {A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice},
  journal = {Virus Research},
  year = {2024},
  doi = {10.1016/j.virusres.2024.199378}
}
Kostenlos starten →